業績
Achievements
- トップ >
- 2020年度
2020年度
| No. | 論文題名 |
|---|---|
| 1 | Long-term safety and efficacy of safinamide as add-on therapy in levodopa-treated Japanese patients with Parkinson's disease with wearing-off: Results of an open-label study. Tsuboi Y, Hattori N, Yamamoto A, Sasagawa Y, Nomoto M; ME2125-4 Study Group. J Neurol Sci. 2020 Sep 15;416:117012 |
| 2 | Efficacy and safety of safinamide as an add-on therapy to L-DOPA for patients with Parkinson's disease: A randomized, double-blind, placebo-controlled, phase II/III study. Hattori N, Tsuboi Y, Yamamoto A, Sasagawa Y, Nomoto M; ME2125-3 Study Group. Parkinsonism Relat Disord. 2020 Jun;75:17-23 |
| 3 | Meta-Analysis of Gut Dysbiosis in Parkinson's Disease. Nishiwaki H, Ito M, Ishida T, Hamaguchi T, Maeda T, Kashihara K, Tsuboi Y, Ueyama J, Shimamura T, Mori H, Kurokawa K, Katsuno M, Hirayama M, Ohno K. Mov Disord. 2020 Sep;35(9):1626-1635 |
| 4 | Short-Chain Fatty Acid-Producing Gut Microbiota Is Decreased in Parkinson's Disease but Not in Rapid-Eye-Movement Sleep Behavior Disorder. Nishiwaki H, Hamaguchi T, Ito M, Ishida T, Maeda T, Kashihara K, Tsuboi Y, Ueyama J, Shimamura T, Mori H, Kurokawa K, Katsuno M, Hirayama M, Ohno K. mSystems. 2020 Dec 8;5(6):e00797-20 |
| 5 | Impact of motor and nonmotor symptoms in Parkinson disease for the quality of life: The Japanese Quality-of-Life Survey of Parkinson Disease (JAQPAD) study. Kurihara K, Nakagawa R, Ishido M, Yoshinaga Y, Watanabe J, Hayashi Y, Mishima T, Fujioka S, Tsuboi Y(corresponding author). J Neurol Sci. 2020 Dec 15;419:117172 |
| 6 | Relationship between tongue pressure and functional oral intake scale diet type in patients with neurological and neuromuscular disorders. Umemoto G, Fujioka S, Arahata H, Kawazoe M, Sakae N, Sasagasako N, Furuya H, Tsuboi Y. Clin Neurol Neurosurg. 2020 Nov;198:106196 |
| 7 | The efficacy and safety of hachimijiogan for mild Alzheimer disease in an exploratory, open standard treatment controlled, randomized allocation, multicenter trial: A study protocol. Kainuma M, Funakoshi K, Ouma S, Yamashita KI, Ohara T, Yoshiiwa A, Murata M, Tsuboi Y. Medicine (Baltimore). 2020 Sep 18;99(38):e22370 |
| 8 | PLA2G6 variants associated with the number of affected alleles in Parkinson's disease in Japan. Daida K, Nishioka K, Li Y, Yoshino H, Shimada T, Dougu N, Nakatsuji Y, Ohara S, Hashimoto T, Okiyama R, Yokochi F, Suzuki C, Tomiyama M, Kimura K, Ueda N, Tanaka F, Yamada H, Fujioka S, Tsuboi Y, Uozumi T, Takei T, Matsuzaki S, Shibasaki M, Kashihara K, Kurisaki R, Yamashita T, Fujita N, Hirata Y, Ii Y, Wada C, Eura N, Sugie K, Higuchi Y, Kojima F, Imai H, Noda K, Shimo Y, Funayama M, Hattori N. Neurobiol Aging. 2020, 97:147.e1-147.e9 |
| 9 | Non-motor symptoms depending on motor severity in Japanese patients with Parkinson's disease: A multicenter cross-sectional study. Toyama M, Okuma Y, Yamamoto M, Kashihara K, Yoshida K, Saiki H, Maeda T, Tsuboi Y, Takahashi Y, Nakayama T. J Neurol Sci. 2020 May 15;412:116641 |
| 10 | Regular use of laxatives influence dose of dopaminergic medication in patients with parkinsonism. Yasutaka Y, Fujioka S, Mishima T, Imakyure O, Tsuboi Y, Kamimura H. Jpn Pharmacol Ther, 48(5), 785-790, 2020 |
| 11 | How to introduce a rotigotine patch to Parkinson's disease patients taking oral dopamine agonists. Yasutaka Y, Fujioka S, Mishima T, Shibaguchi H, Tsuboi Y, Kamimura H. Clin Neurol Neurosurg. 2020 Oct 1;199:106266 |
| 12 | Real-World Nonmotor Changes in Patients with Parkinson’s Disease and Motor Fluctuations: J-FIRST. Watanabe H, Saiki H, Chiu S-W, Yamaguchi T, Kashihara K, Tsuboi Y, Nomoto M, Hattori N, Maeda T, Shimo Y, on behalf of the J-FIRST Group. MOVEMENT DISORDER S CLINICAL PRACTICE 2020; 7(4): 431–439 |
| 13 | Biofeedback Core Exercise Using Hybrid Assistive Limb for Physical Frailty Patients With or Without Parkinson's Disease. Kotani N, Morishita T, Yatsugi A, Fujioka S, Kamada S, Shiota E, Tsuboi Y, Inoue T. Front Neurol. 2020 Apr 9;11:215 |
| 14 | Impact of Residual Drug in the Pharynx on the Delayed-On Phenomenon in Parkinson's Disease Patients. Fukae J, Fujioka S, Umemoto G, Arahata H, Yanamoto S, Mishima T, Tsuboi Y(corresponding author). Mov Disord Clin Pract. 2020 Feb 27;7(3):273-278 |
| 15 | Surgical management of adverse events associated with deep brain stimulation: A single-center experience. Nonaka M, Morishita T, Yamada K, Fujioka S, Higuchi MA, Tsuboi Y, Abe H, Inoue T. SAGE Open Med. 2020 Mar 19;8:2050312120913458 |
| 16 | Beneficial effect of 24-month bilateral subthalamic stimulation on quality of sleep in Parkinson's disease. Dafsari HS, Ray-Chaudhuri K, Ashkan K, Sachse L, Mahlstedt P, Silverdale M, Rizos A, Strack M, Jost ST, Reker P, Samuel M, Visser-Vandewalle V, Evans J, Antonini A, Martinez-Martin P, Timmermann L; EUROPAR, the IPMDS Non Motor P.D. Study Group. J Neurol. 2020 Jun;267(6):1830-1841 |
| 17 | Improvement of Blood Plasmalogens and Clinical Symptoms in Parkinson's Disease by Oral Administration of Ether Phospholipids: A Preliminary Report. Mawatari S, Ohara S, Taniwaki Y, Tsuboi Y, Maruyama T, Fujino T. Parkinsons Dis. 2020 Feb 19;2020:2671070 |
| 18 | Table tennis for patients with Parkinson's disease: A single-center, prospective pilot study. Inoue K, Fujioka S, Nagaki K, Suenaga M, Kimura K, Yonekura Y, Yamaguchi Y, Kitano K, Imamura R, Uehara Y, Kikuchi H, Matsunaga Y, Tsuboi Y(corresponding author). Clinical Parkinsonism & Related Disorders, in press. 2020 Dec |
| 19 | Creation and validation of a bladder dysfunction symptom score for HTLV-1-associated myelopathy/tropical spastic paraparesis. Yamakawa N, Yagishita N, Matsuo T, Yamauchi J, Ueno T, Inoue E, Takata A, Nagasaka M, Araya N, Hasegawa D, Coler-Reilly A, Tsutsumi S, Sato T, Araujo A, Casseb J, Gotuzzo E, Jacobson S, Martin F, Puccioni-Sohler M, Taylor GP, Yamano Y; Japan Clinical Research Group on HAM/TSP. Orphanet J Rare Dis. 2020 Jul 3;15(1):175 |
| 20 | Serum B-type natriuretic peptide level and timing of its measurement as a predictor of acute ischemic stroke outcome. Fukuhara K, Ogata T, Takeshita S, Tsuboi Y(corresponding author). eNeurologicalSci. 2020;18:100217 |
| 21 | アルツハイマー型認知症の経過観察における脳血流SPECT を用いた疾患特異領域評価の有用性の検討．横田梨沙、長町茂樹、野々熊真也、高野浩一、桑原康雄、吉満研吾、尾籠晃司、坪井義夫．臨床放射線 65：649-657，2020 |
| 22 | レビー小体型認知症診断におけるAla ScoreとCIScoreの年齢別感度、特異度の検討．山口裕美子、合馬慎二、野々熊真也、長町茂樹、坪井義夫(corresponding author)．臨床神経学 2020; 60: e407-413 |
| 23 | DLBとADの鑑別診断における脳血流SPECT上のcingulate island score 偽陰性,偽陽性例の検討．佐藤圭亮、長町茂樹、野々熊真也、高野浩一、桑原康雄、吉満研吾、尾籠晃司、坪井義夫．臨床放射線 2020; 65: 141-147 福岡大学病院の入院患者における転倒の現状と取り組みについて．小吉里枝、坪井義夫、鷲山厚司、押川麻美、末松保憲、三浦伸一郎、井上亨.「医療と安全」 2020; 12: 35-40 |
| 24 | Detection and Differentiation of Dural Arteriovenous Fistulas in the Transverse Sinus/Sigmoid Sinus and Cavernous Sinus Using Carotid Ultrasound: Importance of Evaluation of the Occipital Artery. Hisaeda E, Shimada H, Ogata T (corresponding author), Fukuda K, Higashi T, Inoue T. Journal of ultrasound in medicine. 2020;40:683-687 |
| 25 | Feasibility of single and combined with other treatments using transcranial direct current stimulation for chronic stroke: A pilot study. Hyakutake K, Morishita T, et al. SAGE open medicine. 2020;8:2050312120940546 |
| 26 | Qualitative and Comparative Cortical Activity Data Analyses from a Functional Near-Infrared Spectroscopy Experiment Applying Block Design. Saita K, Morishita T, Arima H, Ogata T, Inoue T. Journal of visualized experiments : JoVE. 2020 |
| 27 | Feasibility of Robot-assisted Rehabilitation in Poststroke Recovery of Upper Limb Function Depending on the Severity. Saita K, Morishita T, et al. Neurologia medico-chirurgica. 2020;60:217-22 |
| 28 | An International Survey of Deep Brain Stimulation Utilization in Asia and Oceania: The DBS Think Tank East. Zhang C, Ramirez-Zamora A, Meng F, Lin Z, Lai Y, Li D, Chang J, Morishita T, Inoue T, Fujioka S, Oyama G, Coyne T, Voon V, Doshi PK, Wu Y, Liu J, Patel B, Almeida L, Wagle Shukla AA, Hu W, Foote K, Zhang J, Sun B, Okun MS. Front Hum Neurosci. 2020;14:162 |
| 29 | Global Survey on Telemedicine Utilization for Movement Disorders During the COVID-19 Pandemic. Hassan A, Mari Z, Gatto EM, Cardozo A, Youn J, Okubadejo N, Bajwa JA, Shalash A, Fujioka S, Aldaajani Z, Cubo E; International Telemedicine Study Group. Mov Disord. 2020;35(10):1701-1711 |
| No. | 論文題名 |
|---|---|
| 1 | Myasthenia Gravis with Anti-Muscle-Specific Tyrosine Kinase Antibody during Pregnancy and Risk of Neonatal Myasthenia Gravis: A Case Report and Review of the Literature. Inoue KI, Tsugawa J, Fukae J, Fukuhara K, Kawano H, Fujioka S, Tsuboi Y(corresponding author). Case Rep Neurol. 2020 Mar 17;12(1):114-120 |
| 2 | Isolated Cerebral Vasculitis in the Unilateral Middle Cerebral Artery in a Case with SLE. Takeshita S, Ogata T, Tsugawa J, Tsuboi Y(corresponding author). Intern Med. 2020 Dec 15;59(24):3225-3227 |
| 3 | 軽度のコミュニケーション障害で発症し長期経過を呈した神経軸索スフェロイド形成を伴う遺伝性びまん性白質脳症の1例．横手 顕、合馬慎二、高橋和範、原 文彦、吉田邦広、坪井義夫(corresponding author)．臨床神経学 2020; 60: e420-424 |
| 4 | シリーズ：一目瞭然！目で見る症例．問題編、解答編．横手 顕、坪井義夫(corresponding author)．日本内科学雑誌 2020; 109: 2199-2021 |